Can Hydralazine Cause Restlessness?
Hydralazine does not directly cause restlessness as a recognized adverse effect, but it commonly causes reflex tachycardia and sympathetic nervous system activation that may manifest as symptoms resembling restlessness or agitation.
Mechanism of Sympathetic Activation
Hydralazine is a direct arterial vasodilator that produces marked hemodynamic effects through its "hyperdynamic" circulation 1. When hydralazine lowers blood pressure, it triggers:
- Reflex baroreceptor-mediated tachycardia - The drug consistently increases heart rate through sympathetic activation 2, 3, 4
- Increased cardiac ejection velocity and myocardial stimulation 1, 4
- Enhanced sympathetic tone requiring concurrent beta-blocker therapy to control 5, 6
Clinical Manifestations That May Resemble Restlessness
The sympathetic activation from hydralazine produces several effects that could be interpreted as or contribute to restlessness:
Cardiovascular Stimulation
- Tachycardia occurs in 50-57% of patients receiving hydralazine 3, 7
- Palpitations and increased heart rate awareness
- The magnitude varies significantly between individuals based on baroreceptor sensitivity 3
Hyperdynamic State
The FDA label explicitly warns that hydralazine produces a "hyperdynamic circulation" that can accentuate cardiovascular inadequacies 1. This hyperdynamic state may manifest as:
- Increased cardiac output
- Enhanced sympathetic drive
- Physical sensations of cardiac stimulation
Important Clinical Caveats
Hydralazine should always be combined with a beta-blocker and diuretic when used for resistant hypertension or heart failure, specifically to control the sympathetic activation and sodium retention 5, 6. The 2025 AHA/ACC guidelines emphasize that direct vasodilators like hydralazine "should be used in combination with a BB and a loop diuretic given their effects on sympathetic tone" 6.
Documented Adverse Effects (Not Restlessness)
The FDA label lists specific adverse effects 1:
- Peripheral neuritis (paresthesia, numbness, tingling)
- Postural hypotension
- Anginal attacks from myocardial stimulation
- Blood dyscrasias
- Drug-induced lupus (at doses >150 mg/day)
Restlessness is not listed as a recognized adverse effect in the FDA labeling or major guidelines 8, 9, 10, 11, 1.
Clinical Recommendation
If a patient on hydralazine reports restlessness, consider:
- Evaluate for tachycardia - Check heart rate and rhythm, as the sympathetic activation may be perceived as restlessness
- Assess beta-blocker adequacy - Ensure concurrent beta-blocker therapy is optimized to control reflex tachycardia 5, 6
- Rule out hypotension - Symptomatic hypotension can cause anxiety-like symptoms 1
- Consider alternative causes - Restlessness is not a typical hydralazine effect; investigate other etiologies
The sensation of restlessness, if present, is most likely secondary to the drug's cardiovascular effects (tachycardia, hyperdynamic circulation) rather than a direct central nervous system effect.